Skip to main content

Candel Therapeutics cuts share price to complete IPO

After delaying its listing by a couple of days, immuno-oncology company Candel Therapeutics has made its way to the Nasdaq, but sold its shares for just $8 after originally setting a range of $13-$15 each.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.